Read this article in:
13 November, 2006
ICEM French affiliate FCE-CFDT is demanding that Bayer Pharmaceutical tend to all its social obligations in the German company’s recent announcement of location changes inside France. After last summer’s purchase by Bayer of Schering Pharma, the company announced last week it was moving the offices of the pharmaceutical division from Puteaux near Paris to the northern French town of Lys-lez-Lannoy, just inside the Belgian border.
The pharmaceutical branch of FCE-CFDT warns that 500 jobs could be threatened by the move. “Important social consequences” will arise, FCE-CFDT said in a statement, “because not all Puteaux workers will go north. In addition, there might be collateral consequences for staff of other divisions of the company, including Bayer SAS and Bayer Jardin.”
The union is calling on Bayer to commit itself to propose “an acceptable solution to every worker impacted by the decision,” and FCE-CFDT demands that an extraordinary meeting occur to address the social and economic future of the site at Puteaux.